COMPLETE KIT INCLUDEDbacteriostatic water, syringes, protocol and guide with every order

Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•Certified by ISSCA in Peru and Colombia•ISSCA World Peptide ConferencePERU 2026•

Research guide · Cognitive & Focus

Pinealon — research protocol

Synthetic tripeptide studied for cognitive function and neuroprotection in aging.

Evidence boundary

This guide summarizes study areas and sources associated with the compound. BioPeptideX does not convert experimental information into a clinical regimen or recommend an individual dose, frequency, route or duration.

Catalog presentations

10mg5mg

Concentration table

Mathematical reference only; this is not a dosing recommendation.

Resulting concentration5.00 mg/mL
On a U-100 syringe · 1 unit contains0.050 mg

Research areas

  • Synthetic tripeptide
  • Neuroprotection
  • Sealed sterile vial

Most-cited research protocols

Educational information based on research protocols and literature; it does not replace guidance from a healthcare professional.

Pinealon is a synthetic three-amino-acid peptide (Glu-Asp-Arg) studied for its potential role in brain aging, memory, and nerve-cell stress, aiming to support learning and focus during a research cycle. These benefits are experimental and not yet proven in large human trials.

DoseFrequencyDurationRoute
Subcutaneous Injection1.0 to 2.0 mgOnce daily10 to 20 days (extendable to 28 days)Subcutaneous
Subcutaneous Example Titration (Days 1-5)1.0 mgDaily5 daysSubcutaneous
Subcutaneous Example Titration (Days 6-14)1.5 mgDaily9 daysSubcutaneous
Oral Capsule20 mg2 to 3 cycles per year10 to 20 days (extendable to 28 days)Oral

Cycle: 10 to 20 days, repeated 2 to 3 times per year, with 2 to 3 months off between cycles.

Benefits and research observations: Subjective changes tend to appear after 10 to 14 days of daily use, with sleep quality being the most common early observation (Days 1-7). The cycle ends after 20-28 days, followed by an off-period.

Handling and storage

Store unreconstituted product according to its label and maintain the cold chain where applicable. After any preparation, follow only validated instructions for the specific product and diluent. Do not use if packaging is damaged or the solution shows particles or unexpected changes.

Warnings

Do not use this page for self-diagnosis or self-medication. Pregnancy, breastfeeding, minors, cancer history, allergies, active disease and concurrent treatments require individual professional evaluation.

Published sources

  1. 1.Khavinson VK, et al. Bull Exp Biol Med, 2011.
  2. 2.Anisimov VN. Curr Aging Sci, 2010.